Serum lipoprotein and apolipoprotein levels in ischemic cerebrovascular diseases ISKEMIK SEREBROVASKULER HASTALIKLARDA (ISVH) SERUM LIPOPROTEIN VE APOLIPOPROTEIN DUZEYLERI

Ilhan A., ÖREM A., ALİOĞLU Z., Bolukbasi O., VELİOĞLU S., Ozmenoglu M., ...Daha Fazla

Noropsikiyatri Arsivi, cilt.32, sa.3, ss.157-161, 1995 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 3
  • Basım Tarihi: 1995
  • Dergi Adı: Noropsikiyatri Arsivi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.157-161
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Cerebrovascular diseases are the third cause of mortality following cardiovascular disease and cancer diseases. Risk factors may play a role by accelerating the formation of atherosclerosis and so Ischemic Cerebrovascular Diseases (ICVD). Early detection of atherosclerosis prone persons is extremely important economical and medical burden of ICVD to health budget of the development countries. In this study, we compared the lipoprotein and apolipoprotein levels in ICVD and control group. In ICVD groups, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), and apolipoprotein B-100 (apoB-100) levels were found to be high and statistically significant differences from controls (p < 0.01). Serum apolipoprotein A-I (apoA-I) levels were found to be lower than controls (p < 0.01).